SSRI co‐medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010‐2015

OBJECTIVES: Non‐vitamin K oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) are used for the prophylaxis and treatment of thromboembolic events. A potential drug–drug interaction and increased bleeding events have been reported with co‐medication of selective serotonin receptor inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikh Rezaei, Safoura, Mittlböck, Martina, Reichardt, Bertholdt, Wolzt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767374/
https://www.ncbi.nlm.nih.gov/pubmed/30968457
http://dx.doi.org/10.1002/gps.5117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767374/
https://www.ncbi.nlm.nih.gov/pubmed/30968457
http://dx.doi.org/10.1002/gps.5117

Ejemplares similares